Teva Pharma Industries Stock Price on December 19, 2024
| TEVA Stock | USD 22.09 0.78 3.66% |
Below is the normalized historical share price chart for Teva Pharma Industries extending back to November 07, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Teva Pharma stands at 22.09, as last reported on the 22nd of December, with the highest price reaching 22.17 and the lowest price hitting 21.11 during the day.
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. Teva Pharma appears to be somewhat reliable, given 3 months investment horizon. Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11% return per unit of risk over the last 3 months. We have found thirty technical indicators for Teva Pharma Industries, which you can use to evaluate the volatility of the company. Please review Teva Pharma's Semi Deviation of 1.65, coefficient of variation of 959.51, and Risk Adjusted Performance of 0.0905 to confirm if our risk estimates are consistent with your expectations.
At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 24.9 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 777 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.34, whereas Price To Sales Ratio is forecasted to decline to 0.70. Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of March 1990 | 200 Day MA 16.63 | 50 Day MA 17.8002 | Beta 0.868 |
Teva |
Sharpe Ratio = 0.1061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TEVA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.8 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Teva Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharma by adding it to a well-diversified portfolio.
Price Book 4.1268 | Enterprise Value Ebitda 25.8117 | Price Sales 1.4923 | Shares Float 1.1 B | Wall Street Target Price 23.4756 |
Teva Pharma Main Headline on 19th of December 2024
With a 1.8 percent CAGR, the Opioid Market is Expected to Re... by finance.yahoo.com
Increasing awareness of effective pain management options is expected to drive opioid market growth over the forecast period.New York, USA, Dec. 19, 2024 -- Market Overview The global opioid market is projected to grow from USD 23.70 billion in 2024 to USD 28.45 billion by 2034 at a CAGR of 1.8, as per a recent report by Polaris Market Research. Market Introduction What are Opioids A class of drugs known as opioids is used to treat moderate to severe pain. Opioids can be produ
Teva Pharma Valuation on December 19, 2024
It is possible to determine the worth of Teva Pharma on a given historical date. On December 19, 2024 Teva was worth 21.3 at the beginning of the trading date compared to the closed value of 21.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Teva Pharma stock. Still, in general, we apply an absolute valuation method to find Teva Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teva Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Teva Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 20.45 | 21.98 | 20.40 | 21.20 | 23,680,099 | |
12/19/2024 | 21.30 | 21.64 | 20.98 | 21.31 | 14,458,040 |
| 21.21 | 22.17 | 21.11 | 22.09 | 13,253,195 |
| Backtest Teva Pharma | | | Teva Pharma History | | | Teva Pharma Valuation | Previous | Next |
Teva Pharma Trading Date Momentum on December 19, 2024
| On December 20 2024 Teva Pharma Industries was traded for 22.09 at the closing time. The top price for the day was 22.17 and the lowest listed price was 21.11 . The trading volume for the day was 13.3 M. The trading history from December 20, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 3.66% . The trading price change against the current closing price is 0.47% . |
Teva Pharma Industries Fundamentals Correlations and Trends
By evaluating Teva Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Teva Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Teva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Teva Pharma Stock history
Teva Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharma Industries will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharma stock prices may prove useful in developing a viable investing in Teva Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.1 B | 777 M | |
| Net Loss | -2.1 B | -2 B |
Teva Pharma Stock Technical Analysis
Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Teva Pharma Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Teva Pharma Industries cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Teva Pharma December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns
Teva Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Teva Pharma's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0905 | |||
| Jensen Alpha | 0.4031 | |||
| Total Risk Alpha | 0.2781 | |||
| Sortino Ratio | 0.1769 | |||
| Treynor Ratio | (0.45) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |